Board of Directors

AllerGen NCE Inc. is governed by an independent Board of Directors (BoD) committed to the vision and mission of the Network. Board Directors promote an atmosphere where research excellence and industry expertise unite to provide socio-economic benefits for Canadians. The BoD is responsible for the overall governance of the Network and acts in accordance with the By-Laws of AllerGen NCE Inc.

AllerGen’s BoD ensures that Network management pursues appropriate corporate directions and develops, maintains and implements investments, processes and strategic plans in accordance with Network policies and priorities.

Former Board Members

Current Board Members

Pieter Cullis (Chair) | academic/research, Vancouver BC

CullisPieter Cullis, PhD, FRSC (Chair)

Director, Life Sciences Institute; Director, NanoMedicines Research Group; Chair, Personalized Medicine Initiative; Professor, Department of Biochemistry and Molecular Biology, The University of British Columbia

Dr. Cullis is an internationally recognized pioneer and leader in the physical properties and functional roles of lipids in biological membranes and liposomal drug delivery systems.

Sector: Academic/Research

Donald Green (Vice Chair) | industry, Burlington ON

Don-GreenDonald Green

Chair and CEO, Greenfleet Ltd.

For 35 years, Donald Green was Chair and CEO of the international auto parts manufacturer Tridon Ltd., and is now Chair and CEO of Greenfleet Ltd., a private investment company.

Sector: Industry

Patrick Deane | academic, Hamilton ON

PatrickDeane2014Patrick Deane, PhD

President and Vice-Chancellor, McMaster University

Dr. Deane is the seventh and current president and vice-chancellor of McMaster University.

Sector: Academic (Host Institution)

Judah Denburg | clinical/academic, Hamilton ON

jdsmallJudah Denburg, MD, FRCP(C)

Scientific Director and CEO, AllerGen NCE Inc.

As Scientific Director of AllerGen, Dr. Denburg helps steer an innovative and inter-disciplinary research program. Dr. Denburg’s main research thrusts include examination of the mechanisms of allergic inflammation, with particular emphasis on hemopoietic cytokines and their role in activating the differentiation and recruitment of inflammatory cells such as eosinophils, basophils and mast cells.

Sector: Clinical/Academic

Charles Frankish | clinical, Kanata ON

FrankishCharles Frankish, MD, FRCP(C)

Allergist and Clinical Immunologist, Kanata Allergy Services

Dr. Frankish is an allergist and clinical immunologist at Kanata Allergy Services in Kanata, ON.

Sector: Clinical

Christine Hampson | non-profit, Toronto ON

hampsonChristine Hampson, PhD

President and CEO, The Sandbox Project

Dr. Hampson is President & CEO of The Sandbox Project Charity, which aims to make measurable progress against international health indicators within the next five years, improving health outcomes with respect to injury prevention, obesity, mental health, and the environment in particular.

Sector: Non-Profit

Jean-François LePrince | private, Montreal QC

LeprinceJean-François LePrince

Managing Partner, CTI Life Sciences Fund

Mr. Leprince has over 30 years of experience with large pharmaceutical companies; he has overseen the largest R&D spending of any of the multinational pharmaceutical companies operating in Canada.

Sector: Private

Piush Mandhane | clinical/academic, Edmonton AL

Piush Mandhane, MD, FRCPC

Associate Professor, Pediatric Respiratory Medicine, University of Alberta

Dr. Mandane is the Edmonton site leader of AllerGen’s CHILD Study.

Sector: Clinical/Academic

Tia Moffat (observer) | NCE Secretariat

moffatTia Moffat (observer)

Senior Program Manager, NCE Secretariat

Tia Moffat has extensive experience in research, grant administration and program delivery.

Daniel Nixon | private, Toronto ON

nixonDaniel Nixon, MBA

Director & Chief Financial Officer, Molecular You Corporation

Mr. Nixon is a seasoned executive with extensive private equity, investment banking and operations experience.

Sector: Private

Diana Royce (observer) | AllerGen NCE

dianaroyceDiana Royce, EdD (observer)

Managing Director and COO, AllerGen NCE Inc.

Dr. Royce has over 30 years of experience in the post-secondary and health sectors related to public consultation and research, program implementation, strategic and operational planning, network administration, partnership and public policy development, advocacy, fundraising, knowledge mobilization, conference planning and meeting facilitation.

Amrit Singh (observer) | AllerGen NCE

Amrit Singh, PhDAmirt (observer)

President, ASNPN

Dr. Singh is a post-doctoral fellow  at the PROOF (Prevention of Organ Failure) Centre, working under Dr. Bruce McManus. He received his PhD in Experimental Medicine from The University of British Columbia in 2016.

Donald Stark | clinical/academic, Vancouver BC

StarkDonald Stark, MD, FRCP(C)

Clinical Associate Professor, Department of Medicine, The University of British Columbia

Dr. Stark was president of the Canadian Society of Allergy and Clinical Immunology from 1990 to 1992 and was instrumental in setting up the Canadian Allergy, Asthma and Immunology Foundation, serving as its first Chairman.

Sector: Clinical/Academic

Lorne Tyrrell | clinical/academic, Edmonton, AB

TyrrellLorne Tyrrell, OC, AOE, MD, PhD, FRCP(C), FRSC, FCAHS

Distinguished University Professor and Director, LiKaShing Institute of Virology, University of Alberta

Dr. Tyrrell, an exceptional teacher, compassionate physician and accomplished researcher, has positioned the University of Alberta and Canada as a world leader in hepatitis research and treatment. He was awarded a Killam Prize in 2015.

Sector: Clinical/Academic

Russell Wiliams | non-profit, Ottawa, ON

Russell Williams

Vice-President Government Relations and Public Policy, Canadian Diabetes Association

Russell Williams is a passionate advocate for Canadian health research, innovation in health care, and integrity in the pharmaceutical and medical fields. He received the inaugural Research Canada Leadership Award in 2014. In 2016, a Studentship in Medical Ethics at Queen’s University was created in his honour.

Sector: Non-profit